InTest Downstream CAPEX Cycle Showing Decline After Q2 26 Results
InTest reported Q2 26 results amid signs of decline in its downstream capex cycle. The stock has nearly doubled on order and backlog recovery, but profits have lagged revenue growth. The analysis maintains a Hold view, citing skepticism about earnings leverage and whether recent revenue gains are sustainable at the current valuation.